DONG PEIXIN

Affiliation and department：
Homepage URL (2)： http://www.researchgate.net/profile/Peixin_Dong , https://scholar.google.com/citations?user=Ze3zls4AAAAJ&hl=ja

Research field (4)： Molecular biology , Obstetrics and gynecology , Genomics , Tumor biology

Research keywords (16)： Long non-coding RNA , PD-L1 , 子宮体癌 , p53 , Non-coding RNA , Tumor cell biology , metastasis , cancer stem cell , epigenetics , EZH2 , 子宮頸癌 , 子宮内膜癌 , EMT , 癌転移 , microRNA , cancer

Research theme for competitive and other funds (8)：

2022 - 2025 Comprehensive Search for Early Diagnostic Markers and Therapeutic Targets for Cervical Cancer Using Circular RNA in Blood
2022 - 2025 RNA-binding protein-lncRNA interactions provide new insights into the regulation of endometrial cancer pathology
2019 - 2022 B7H3 as a promising therapeutic target for endometrial cancer
2018 - 2021 The oncogenic role of PD-Li in cervical cancer
2016 - 2019 Elucidation of the miRNA-EZH2 feedback loop regulating endometrial cancer microenvironment

Show all

Papers (68)：

Soudeh Ghafouri-Fard, Hamed Shoorei, Peixin Dong, Yadollah Poornajaf, Bashdar Mahmud Hussen, Mohammad Taheri, Nader Akbari Dilmaghani. Emerging functions and clinical applications of exosomal microRNAs in diseases. Non-coding RNA Research. 2023. 8. 3. 350-362
Soudeh Ghafouri-Fard, Hamed Shoorei, Bashdar Mahmud Hussen, Peixin Dong, Tianyue Zhai, Mohammad Taheri, Mohammad Samadian. The significance of N6-methyladenosine-modified non-coding RNAs in different disorders. European Journal of Pharmacology. 2023. 175644-175644
Yu Miao, Yosuke Konno, Baojin Wang, Lin Zhu, Tianyue Zhai, Kei Ihira, Noriko Kobayashi, Hidemichi Watari, Xin Jin, Junming Yue, et al. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer. Journal of Translational Medicine. 2023. 21. 1
Ghafouri-Fard S, Khoshbakht T, Hussen BM, Dong P, Gassler N, Taheri M, Baniahmad A, Dilmaghani NA. A review on the role of cyclin dependent kinases in cancers. Cancer Cell International. 2022. 22. 1
Yi Li, Anqi Wu, Lin Chen, Aiting Cai, Yuhao Hu, Zhou Zhou, Qianyi Qi, Yixuan Wu, Donglin Xia, Peixin Dong*, Shaoqing Ju* and Feng Wang*. Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin. Journal of Experimental & Clinical Cancer Research. 2022. 41. 1

ｍore...

MISC (18)：

中谷真紀子, 渡利英道, 王磊, 畑中豊, 畑中佳奈子, 西原広史, 朝野拓史, 遠藤大介, 三田村卓, 董培新, et al. 卵巣明細胞腺癌に対するcabozantinibの抗腫瘍効果についての検討. 日本婦人科腫瘍学会雑誌. 2017. 35. 3. 628-628
Ihira Kei, Dong Peixin, Mitamura Takashi, Konno Yosuke, Kato Tatsuya, Kobayashi Noriko, Takeda Mahito, Watari Hidemichi, Kudo Masataka, Minakami Hisanori, et al. ISP-11-6 EZH2 stimulates Twist expression by epigenetic silencing of its suppressor miR-361 through an YY1-dependent mechanism(Group 11 Oncology 3,International Session Poster) :. 2016. 68. 2. 508-508
Hanley Sharon, Dong Peixin, Fujita Hiromasa, Watari Hidemichi, Kobayashi Noriko, Kudo Masataka, Sakuragi Noriaki. ISP-5-6 HPV self-sampling is effective for engaging non-responders in cervical screening and identifying cervical abnormalities(Group 5 Cervical Cancer 4,International Session Poster) :. 2016. 68. 2. 491-491
P. Dong. MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. EUROPEAN JOURNAL OF CANCER. 2015. 51. S12-S12
金野陽輔, 董培新, 鈴木史彦, 櫻木範明. MicroRNA-101は高悪性度子宮体癌の悪性形質を抑制する. 日本婦人科腫よう学会雑誌. 2015. 33. 3. 535

ｍore...

Books (1)：

Endometrial cancer
Future Science Group, London, UK 2014

Lectures and oral presentations (30)：

Control of PD-L1 expression by miR-140/142/340/383 in cervical cancer
(The 2nd World Conference of Immuno-Oncology-2019 2019)
miR-137 and miR-34a directly target snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
(The 12th World Congress of Regenerative Medicine & Stem Cell-2018 2018)
高悪性度子宮体癌細胞に対するEZH2特異的阻害剤の抗腫瘍効果とその分子機構
(第27回日本癌病態治療研究会 2018)
高悪性度体がんのジェネティック・エピジェネティック研究
(「総合女性医療システム学分野」記念シンポジウム 2018)
Epigenetic aspects of endometrial cancer progression: Insights into interactions of EZH2 and microRNAs
(The 4th International Obstetrics & Gynecology Summit · The Red House Forum 2017)

ｍore...

Education (2)：

2004 - 2008 北海道大学大学院医学研究科婦人科博士課程
1992 - 1997 Harbin Medical University, China Medicine M.D.

Professional career (1)：

MD, PhD (Hokkaido University)

Work history (4)：

2010/04 - 現在北海道大学医学研究院産婦人科
2008/04 - 2010/03 復旦大学付属産婦人科病院講師
2002/10 - 2004/03 Fukuoka University Faculty of Medicine
1997/09 - 2002/09 ハルビン医科大学産婦人科医師

Committee career (26)：

2023/03 - 現在国際誌Functional & Integrative Genomics Associate Editor
2023/02 - 現在国際誌European Journal of Medical Research Associate Editor
2022/11 - 現在国際誌Biomarker Insights Editorial Board Member
2022/10 - 現在国際誌Current Drug Targets Associate Editor
2022/10 - 現在国際誌Cancers Editorial Board Member

Show all

Awards (3)：

2023/05 - JSOG Congress Encouragement Award
2016/02 - Hokkaido University President's Award for Outstanding Research (February 3, 2016)
2012/10 - The 92nd Hokkaido Medical Congress Award

Association Membership(s) (3)：

日本産婦人科学会 , 北海道産婦人科学会 , 日本RNA学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page